EUVIMEDScopri EUVIMED
Open access

Strain-specific epistasis shapes fitness landscapes of APOBEC3G antagonism by HIV-1 Vif proteins

Caroline A Langley iD, Michelle Lilly iD, Harmit S Malik iD, Michael Emerman iD

Science Advances · 2026-07-24 · 12 (30)

DOI: 10.1126/sciadv.aed4872 ↗

At a glance

Journal article in Science Advances, published on 2026-07-24. Written by Caroline A Langley and 3 co-authors. Institution: Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA, USA. Major MEDLINE topics: Epistasis, Genetic, APOBEC-3G Deaminase, HIV-1, vif Gene Products, Human Immunodeficiency Virus. 87 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, NIAID NIH HHS, National Institutes of Health.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Host immune factors shape viral evolution. The HIV-1 viral infectivity factor (Vif) protein counteracts host Apolipoprotein B Messenger RNA Editing Enzyme Catalytic Polypeptide–like 3 (A3G) to ensure productive infection. Using deep mutational scanning across two divergent HIV-1 Vif proteins, we systematically mapped and compared the mutational landscapes governing Vif antagonism of A3G. These high-resolution fitness maps reveal core principles of host-virus coevolution. Most missense mutations were strongly deleterious, reflecting pervasive purifying selection. However, several highly conserved Vif residues at binding interfaces with A3G, RNA, and core-binding factor β exhibited unexpected mutational tolerance, indicating structural flexibility at these sites. Comparative analysis revealed that strain-specific epistasis dictates Vif-A3G interactions, including adaptive changes at the Vif-A3G interface. Further analysis uncovered notable temporal epistasis, whereby initially adaptive Vif mutations critical for antagonizing hominoid A3G subsequently exhibited reduced fitness. Thus, structural robustness permits adaptation, while epistasis imposes constraints on Vif’s ability to maintain A3G antagonism while remaining responsive to new evolutionary pressures.

Subjects

MeSH terms (MEDLINE)

Epistasis, GeneticAPOBEC-3G DeaminaseHIV-1vif Gene Products, Human Immunodeficiency VirusGenetic FitnessHumansMutationEvolution, MolecularProtein BindingHost-Pathogen Interactions

Substances

APOBEC-3G Deaminasevif Gene Products, Human Immunodeficiency VirusAPOBEC3G protein, humanvif protein, Human immunodeficiency virus 1

Authors and institutions

  • Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA, USA.
  • Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Division of Basic Science, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Howard Hughes Medical Institute, Fred Hutchinson Cancer Center, Seattle, WA, USA.

ORCID profiles: Caroline A Langley, Michelle Lilly, Harmit S Malik, Michael Emerman

Funding

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • Howard Hughes Medical Institute
  • University of Washington Cellular and Molecular Biology Training Grant

Cite

APA

Langley, C. A., Lilly, M., Malik, H. S., & Emerman, M. (2026). Strain-specific epistasis shapes fitness landscapes of APOBEC3G antagonism by HIV-1 Vif proteins. Science Advances, 12(30). https://doi.org/10.1126/sciadv.aed4872

Vancouver

Langley CA, Lilly M, Malik HS, Emerman M. Strain-specific epistasis shapes fitness landscapes of APOBEC3G antagonism by HIV-1 Vif proteins. Science Advances. 2026;12(30). doi:10.1126/sciadv.aed4872

BibTeX
@article{Langley2026,
  author = {Langley, Caroline A and Lilly, Michelle and Malik, Harmit S and Emerman, Michael},
  title = {Strain-specific epistasis shapes fitness landscapes of APOBEC3G antagonism by HIV-1 Vif proteins},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {30},
  doi = {10.1126/sciadv.aed4872}
}
Start for free →